Clarium key facts
as of Oct 2026- Developer of an artificial intelligence-based platform designed to automate healthcare business operations.
- Clarium is valued at approximately $140.0M as of Oct 2026 (last reported valuation).
- It has raised $42.5M; the latest was Later Stage VC ($27.0M) in May 2025.
- Notable investors include Alumni Ventures, General Catalyst, Texas Medical Center, AlleyCorp, Northzone Ventures — 14 tracked in total.
- Status: Privately Held (backing).
Clarium's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·The complete investor list: 14 names
- ·Watch Clarium: the Monday email on marks, rounds and moves
Clarium funding rounds
No funding rounds for Clarium are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Clarium
14+Clarium valuation
Clarium's last reported valuation was $140 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
Clarium investors
14 investors are on record for Clarium, including Alumni Ventures, General Catalyst, Texas Medical Center and AlleyCorp. By type, the record holds 8 venture capital firms and 1 hedge fund.
About Clarium
Developer of an artificial intelligence-based platform designed to automate healthcare business operations. The company's platform collects data from the existing systems and filters for noise, error, and outliners to predict demand and automate staffing and supplies, enabling hospitals and healthcare centers to avoid shortages and stockouts, reduce supplier lead times, and identify alternative products.
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 37
- Website
- clariumhealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.